Thorne HealthTech, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Paul F. Jacobson
- Full Time Employees
- 544
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 152 West 57th Street New York City NY United States of America 10019
- IPO Date
- Sep 23, 2021
- CIK
- 0001844280
- Website
- thorne.com
- Similar Companies
- Business
- Thorne HealthTech, Inc. (NASDAQ: THRN) operates as a science-driven wellness company providing personalized health testing, premium nutritional supplements, and related services to consumers, healthcare professionals, professional athletes, and sports teams worldwide. Founded in 1984 and headquartered in New York, New York, with manufacturing in Summerville, South Carolina, the company offers core products including at-home biomarker tests for sleep, stress, weight management, gut health, heavy metals, and biological age; nutritional supplements such as nicotinamide riboside (NR)-based formulas like Collagen Fit and Daily Greens Plus, Metabolic Health with bergamot and curcumin, Ovarian Care, Ashwagandha, Creatine + Alpha GPC, and brain health solutions; Health Intelligence platform for personalized recommendations via multi-omics data and neural networks; and wellness education powered by its Onegevity and Discovery platforms. Thorne serves global markets through direct-to-consumer channels, healthcare practitioners, and partnerships, including collaborations with the Mayo Clinic for research, over 12 USA sports teams, and Olympic athletes, while maintaining NSF Certified for Sport verification, TGA A-rating, and cGMP-certified facilities emphasizing absorbable, clinically validated ingredients free of fillers. Recent developments include the completion of its $680 million take-private acquisition by L Catterton in August 2023, delisting from NASDAQ; the $5 million acquisition of PreCon Health in January 2023 to bolster its brain health portfolio with traumatic injury formulas and intellectual property; the launch of Thorne Ventures as an innovation arm in December 2023 to invest in health technologies; and ongoing expansions in personalized offerings like new supplement lines targeting stress, cognition, metabolism, and women's health.
Thorne HealthTech taps former Vitamin Shoppe CEO Watts as leader
L Catterton Completes Acquisition of Thorne HealthTech, Inc.
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
THORNE HEALTHTECH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thorne HealthTech, Inc. -THRN
THORNE HEALTHTECH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thorne HealthTech, Inc. -THRN
Shareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L Catterton
THRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Thorne HealthTech, Inc. Is Fair to Shareholders
Thorne HealthTech stock posts big gain on go-private merger with L Catterton
Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
THRN vs. HQY: Which Stock Should Value Investors Buy Now?
Thorne HealthTech, Inc (THRN) Q2 2023 Earnings Call Transcript
Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8
Thorne HealthTech to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10
3 Penny Stocks Set to Pass the $5 Mark Soon
Thorne HealthTech, Inc. (THRN) Q1 2023 Earnings Call Transcript
Thorne HealthTech, Inc. (THRN) Q4 2022 Earnings Call Transcript
Thorne HealthTech: Strong Fundamental Potential But Cost Pressure Remains
Thorne HealthTech, Inc. (THRN) Q3 2022 Earnings Call Transcript
Thorne HealthTech Announces Third Quarter 2022 Earnings Release Date and Conference Call